Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05026853 · ClinicalTrials.gov registry record · NA
Patient-Reported Outcomes Measurement Information System Integration Into Rheumatology Clinical Practice
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT05026853: Completed NA study, sponsored by University of Michigan.
NCT05026853 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05026853, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
This study will examine the impact of providing patient-reported outcomes measurement information system (PROMIS) scores to patients before appointments with their healthcare provider.
Primary Outcome
Documentation in EMR notes will be categorized as either 'yes' or 'no' and identified through EMR data pulls. Percent of appointments is shown by the count (and percentage) of participants for whom PROMIS scores were documented in the EMR for their appointment.
Interventions
- BEHAVIORAL PRO Integration into Clinical Practice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2021-09-14 |
| Est. Completion | 2023-05-26 |
| Phase | NA |
What the finished NCT05026853 record still lists
NCT05026853 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which PRO Integration into Clinical Practice is the first listed.
NCT05026853 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05026853 about?
NCT05026853 is a clinical study titled "Patient-Reported Outcomes Measurement Information System Integration Into Rheumatology Clinical Practice". This study will examine the impact of providing patient-reported outcomes measurement information system (PROMIS) scores to patients before appointments with their healthcare provider.
What is the current status of trial NCT05026853?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2021-09-14. Estimated completion is 2023-05-26.
What interventions are being tested in trial NCT05026853?
The interventions under investigation include: PRO Integration into Clinical Practice (BEHAVIORAL).
Who is sponsoring clinical trial NCT05026853?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05026853's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI